Journal
JOURNAL OF VETERINARY INTERNAL MEDICINE
Volume 28, Issue 1, Pages 144-153Publisher
WILEY
DOI: 10.1111/jvim.12240
Keywords
Blood pressure; Cats; Chronic kidney disease
Categories
Funding
- Waltham Centre for Pet Nutrition, Waltham-on-the-Wolds, Melton Mowbray, UK
- PetPlan Charitable Trust, Brentford, Middlesex, UK
Ask authors/readers for more resources
BackgroundRole of renin-angiotensin aldosterone system (RAAS) in feline systemic hypertension is poorly understood. ObjectivesExamine plasma renin activity (PRA) and plasma aldosterone concentrations (PAC) in normotensive and hypertensive cats with variable renal function and in response to antihypertensive therapy. AnimalsOne hundred and ninety-six cats >9years from first opinion practice. MethodsPRA, PAC, and aldosterone-to-renin ratio (ARR) were evaluated in cats recruited prospectively and grouped according to systolic blood pressure (SBP) and renal function (nonazotemic normotensive [Non-Azo-NT], nonazotemic hypertensive [Non-Azo-HT], azotemic normotensive [Azo-NT], azotemic hypertensive [Azo-HT]). Changes in PRA and PAC were evaluated with antihypertensive therapy (amlodipine besylate). ResultsPlasma renin activity (ng/mL/h; P=.0013), PAC (pg/mL; P<.001), and ARR (P=0.0062) differed significantly among groups. PRA (ng/mL/h) was significantly lower in hypertensive (Non-Azo-HT; n=25, median 0.22 [25th percentile 0.09, 75th percentile 0.39], Azo-HT; n=44, 0.33 [0.15, 0.48]) compared with Non-Azo-NT cats (n=57, 0.52 [0.28, 1.02]). Azo-HT cats had significantly higher PAC (n=22, 149.8 [103.1, 228.7]) than normotensive cats (Non-Azo-NT; n=26, 45.4 [19.6, 65.0], Azo-NT; n=18, 84.1 [38.6, 137.8]). ARR was significantly higher in Azo-HT (n=20, 503.8 [298.8, 1511]) than Azo-NT cats (n=16, 97.8 [77.0, 496.4]). Significant increase in PRA was documented with antihypertensive therapy (pretreatment [n=20] 0.32 [0.15-0.46], posttreatment 0.54 [0.28, 1.51]), but PAC did not change. Conclusions and Clinical ImportanceHypertensive cats demonstrate significantly increased PAC with decreased PRA. PRA significantly increases with antihypertensive therapy. Additional work is required to determine the role of plasma aldosterone concentration in the pathogenesis of hypertension and whether this relates to autonomous production or activation of RAAS without demonstrable increase in PRA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available